Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Cancer Institute (NCI)
OBJECTIVES:
Primary
* Determine the incidence of the D104N COL18A1 polymorphism in patients with prostate cancer.
Secondary
* Determine the incidence of this polymorphism in African-American patients with prostate cancer.
OUTLINE: This is a retrospective, multicenter study.
DNA is extracted from preexisting serum samples and polymerase chain reaction is performed to determine the genotype pattern.
PROJECTED ACCRUAL: A total of 500 patients and 250 healthy participants will be accrued for this study.
Age
Any age
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
DISEASE CHARACTERISTICS:
Diagnosis of prostate cancer OR healthy participant
Patient enrolled on an IRB-approved clinical trial at the National Cancer Institute or Northwestern University, including, but not limited to, any of the following:
